Full Library

Return to list of results

IDSA COVID-19 Guideline, Part 1: Treatment and Management

RIS

Recommended format for most reference management software

BibTeX

Recommended format for BibTeX-specific software

Open in Zotero
View on zotero.org
Resource type
Web Page
Author/contributor
Title
IDSA COVID-19 Guideline, Part 1: Treatment and Management
Abstract
COVID-19 is a pandemic with a rapidly increasing incidence of infections and deaths. Many pharmacologic therapies are being used or considered for treatment. Given the rapidity of emerging literature, IDSA felt the need to develop living, frequently updated evidence-based guidelines to support patients, clinicians and other health-care professionals in their decisions about treatment and management of patients with COVID-19 infection. Summarized here are the recommendations with comments related to the clinical practice guideline for the treatment and management of COVID-19.
Date
5/30/2025
URL
https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/
Accessed
12/2/20, 8:20 AM
Short Title
COVID-19 Guideline, Part 1
Language
en
Citation
Adarsh Bhimraj*, Rebecca L. Morgan**, Amy Hirsch Shumaker, Valery Lavergne**, Lindsey Baden, Vincent Chi-Chung Cheng, Kathryn M. Edwards, Rajesh Gandhi, Jason Gallagher, William J. Muller, John C. O’Horo, Shmuel Shoham, M. Hassan Murad**, Reem A. Mustafa*. (2025, May 30). IDSA COVID-19 Guideline, Part 1: Treatment and Management. https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/
GUIDELINES
CORE CURRICULUM
ORGANISMS
Link to this record
https://transplantid.net/KQPIJ9A2